0.2548
-0.0027
(-1.05%)
At close: April 17 at 4:00:00 PM EDT
0.2669
+0.01
+(4.75%)
After hours: April 17 at 7:56:58 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | 0 | 0 | -0.41 | 0 |
| Low Estimate | 0 | 0 | -0.41 | 0 |
| High Estimate | 0 | 0 | -0.41 | 0 |
| Year Ago EPS | -- | -- | -0.51 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 1 |
| Avg. Estimate | -- | -- | -- | 7.7M |
| Low Estimate | -- | -- | -- | 7.7M |
| High Estimate | -- | -- | -- | 7.7M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -- | -0.14 | -0.13 | -0.11 |
| EPS Actual | -0.14 | -0.28 | -0.14 | -0.09 |
| Difference | -- | -0.14 | -0.01 | 0.02 |
| Surprise % | -- | -100.00% | -7.69% | 18.18% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.41 | 0 |
| 7 Days Ago | 0 | 0 | -0.48 | 0 |
| 30 Days Ago | 0 | 0 | -0.48 | 0 |
| 60 Days Ago | 0 | 0 | -0.48 | 0 |
| 90 Days Ago | 0 | 0 | -0.48 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVM | -- | -- | 19.61% | -- |
| S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
| Reiterates | EF Hutton: Buy to Buy | 7/12/2023 |
| Reiterates | EF Hutton: Buy | 3/9/2023 |
| Maintains | EF Hutton: Buy | 12/29/2022 |
| Initiated | EF Hutton: Buy | 4/7/2022 |
| Initiated | HC Wainwright & Co.: Buy | 1/13/2020 |
| Initiated | Taglich Brothers: Speculative Buy | 2/20/2013 |
Related Tickers
NWBO Northwest Biotherapeutics, Inc.
0.3500
-0.57%
VRAX Virax Biolabs Group Limited
0.9935
-3.54%
PSTV Plus Therapeutics, Inc.
0.6586
-1.95%
THTX Theratechnologies Inc.
2.5200
-1.95%
CDT Conduit Pharmaceuticals Inc.
0.6201
-20.51%
BDRX Biodexa Pharmaceuticals Plc
1.4300
-0.69%
PTN Palatin Technologies, Inc.
0.2200
-10.57%
CHRO Channel Therapeutics Corporation
1.8400
+46.61%
DWTX Dogwood Therapeutics, Inc.
4.2700
+14.48%
ARTL Artelo Biosciences, Inc.
0.9538
+2.56%